🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Medtronic nudges profit forecast on medical devices demand, new launches

Published 08/20/2024, 07:02 AM
Updated 08/20/2024, 09:50 AM
© Reuters. FILE PHOTO: Medtronic Plc logo is seen displayed in this illustration taken, April 10, 2023. REUTERS/Dado Ruvic/Illustration/File Photo
MDT
-

By Sriparna Roy and Puyaan Singh

(Reuters) -Medtronic slightly lifted the lower end of its annual profit forecast on Tuesday, banking on sustained demand for its medical devices and growth from its new launches, sending its shares up 1.6%.

Investor expectations from medical device makers remain high as they have been benefiting from elevated demand for non-urgent surgeries over the last few quarters.

The company said it was expecting steady growth as it introduces new products and continues to make investments to support those launches.

Earlier this month, the company won the U.S. health regulator's nod for its disposable, all-in-one continuous glucose monitor (CGM), Simplera.

It also announced a partnership under which Abbott's CGM system will connect to Medtronic (NYSE:MDT)'s automated insulin delivery systems.

The Ireland-based company also eyes growth across segments such as diabetes and devices for heart disease-focused surgeries.

Medtronic also remains "on the hunt" for the right tuck-in deals. "I don't want to point out specific areas other than the high growth areas - whether they be a product, tuck into an existing business ... That's where we're focused," said CEO Geoff Martha on a conference call.

The company raised the lower end of its 2025 adjusted profit forecast to $5.42 per share from $5.40 apiece earlier, keeping the upper end at $5.50. Analysts, on average, were expecting profit of $5.44 for 2025, according to LSEG data.

It expects profit growth to accelerate in the back half of the year as the impact from foreign currency lessens.

The delivery, particularly pockets of strength, and the raised outlook was a nice surprise, said Citi analyst Joanne Wuensch.

© Reuters. FILE PHOTO: Medtronic Plc logo is seen displayed in this illustration taken, April 10, 2023. REUTERS/Dado Ruvic/Illustration/File Photo

The company posted a revenue beat across segments except for its medical surgical unit, which was affected by a slowdown in the Korean market due to the ongoing physician strikes.

Medtronic posted adjusted profit of $1.23 per share for the first quarter, beating estimates of $1.20.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.